Nerandomilast, an investigational agent, met the primary endpoint of both phase III trials, FIBRONEERtm-IPF and FIBRONEERtm-ILD, significantly reducing the decline in forced vital capacity (FVC) [mL] ...

Illumina India Biotechnology Private Limited is an Indian Non-Government Company. It's a private company and is classified as'company limited by shares'. Company's authorized capital stands at Rs 1300 ...